Best Time of Day to Take Rexulti
Rexulti (brexpiprazole) should be taken once daily at a consistent time, and can be administered either in the morning or evening with or without food, based on individual tolerability—specifically, take it in the evening if sedation occurs, or in the morning if it causes insomnia or activating effects. 1
Dosing Flexibility and Timing Considerations
The FDA label explicitly states that Rexulti should be "administered orally once daily with or without food," without specifying a particular time of day 1. This flexibility allows for individualized timing based on the patient's side effect profile and daily routine.
Key Factors for Timing Selection
Sedation Profile:
- If the patient experiences daytime sedation or drowsiness, administer the dose at bedtime to leverage this effect for sleep and minimize daytime impairment
- Sedation is a recognized side effect of atypical antipsychotics, and timing can be strategically used to improve tolerability
Activating Effects:
- If the patient experiences insomnia, restlessness, or akathisia (the most common extrapyramidal symptom with brexpiprazole 2, 3), administer the dose in the morning
- This prevents interference with nighttime sleep while maintaining therapeutic efficacy
Food Intake:
- The pharmacokinetics of brexpiprazole are not significantly affected by food 1, so timing relative to meals is not critical
- Patients can take it with breakfast, dinner, or independent of meals based on what promotes adherence
Practical Implementation
Initial Dosing Strategy:
- Start with morning administration during the titration phase to monitor for activating side effects during waking hours
- If sedation becomes apparent during titration (particularly when moving from 0.5-1 mg to 2 mg), switch to evening dosing
- Once the target dose is reached and tolerability is established, maintain consistent timing to optimize steady-state plasma levels
Common Pitfalls to Avoid:
- Do not switch timing frequently—maintain consistency once a schedule is established
- Do not assume all patients will experience the same side effect profile; monitor individually during the first 2-4 weeks
- Do not delay dose adjustments if timing-related side effects emerge; address them promptly to maintain adherence
Clinical Context
The evidence shows that brexpiprazole takes 6-12 weeks to demonstrate full efficacy for agitation in Alzheimer's disease 4 and requires proper titration over 1-2 weeks to reach therapeutic doses 2, 5. The timing of administration does not affect this efficacy timeline but can significantly impact tolerability and adherence during this critical period.
The bottom line: Choose evening dosing if sedation is present, morning dosing if activation or insomnia occurs, and maintain consistency once established. The lack of food effect means patients can align dosing with their most reliable daily routine to maximize adherence.